LR607

· Zhujiang Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LR607, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer [Phase 2]